NorthEdge drives 3x return on cross-border DHG sale – NorthEdge Capital has completed the sale of Direct Healthcare Group (DHG) in a secondary buyout by European healthcare specialist investor ArchiMed. The deal sees NorthEdge secure a 3x return on its initial investment, with an IRR of 39 per cent. NorthEdge led a management buyout of…
ArchiMed, European private equity healthcare specialist, announces successful growth of its portfolio company Micromed into Neurodiagnostics – on both sides of the Atlantic. Archimed expands neurodiagnostic business in Europe and the US Portfolio Company, Micromed, a European-based neurodiagnostic system manufacturer has moved to direct sales in the United States and its wholly owned subsidiary, US based Moberg…
Specialist healthcare investor ArchiMed has acquired a majority stake in Netherlands-based Soest Medical Group (SMG) which produces adhesives used during surgery. SMG has two brands: seller of reusable adhesives Eurotape and disposable adhesives provider Somed. Its revenues are growing at a rate of around 10 per cent annually, according to ArchiMed. With ArchiMed’s backing, SMG…
France-based ArchiMed, a healthcare-focused private equity firm, have hired Benoît Adelus and André-Michel Ballester as partners. Adelus was the chairman and CEO of Sebia while Ballester is currently chairman of ArchiMed portfolio company Citieffe. PRESS RELEASE February 12, 2018 – Benoît Adelus and André-Michel Ballester are joining the senior management of European private equity healthcare…
Marseille, April 23, 2018 – Provepharm Life Solutions announces today that ArchiMed and Téthys Invest have joined the company’s shareholder base as minority investors. Both are renowned investors with strong expertise in the healthcare sector. Beyond financial considerations, it was the specific support for the company’s long-term growth project and the entrepreneurial track record of its…
ACTUS Archimed atteint son hard cap à 315 millions d’euros pour son fonds 2 19.09.17 – Benoît PELEGRIN Il a seulement fallu trois mois et demi à Denis Ribon, président d’Archimed, et son équipe pour boucler la levée du deuxième millésime d’Archimed. Le fonds d’investissement fondé en 2014 par l’ancien responsable de la Santé chez…